How to Read a Retatrutide Certificate of Analysis

Reading a retatrutide certificate of analysis means working through a small number of standardized fields, each of which answers a different question about the vial: what molecule is actually present, how much of it is present relative to impurities, how much mass is in the vial, and whether the batch was tested for contamination. A certificate of analysis, usually abbreviated COA, is a lab report tied to a specific production lot, not a general product description, and knowing what each section is supposed to confirm makes it possible to compare documentation across suppliers on equal footing.

What a Certificate of Analysis Actually Documents

A COA is issued by a testing lab, either in-house at the manufacturer or a third-party contract lab, and it reports the results of specific analytical methods run against a sample pulled from a defined production batch. It is not a marketing document and it is not a safety certification in the regulatory sense — it is a record of what a set of instruments measured on a particular date, tied to a lot number. The value of the document depends entirely on whether the tests it lists are the right ones to answer the question a reader actually has, which for most retatrutide listings comes down to identity and purity.

Identity Testing: Confirming What Is Actually in the Vial

The identity section of a retatrutide certificate of analysis is meant to answer a narrower question than purity: does the sample match the reference structure of the intended peptide at all, regardless of how clean it is. This is typically established through high-performance liquid chromatography (HPLC) compared against a reference standard’s retention time, mass spectrometry (MS) confirming the measured molecular weight against the expected value, or both together. A COA that reports a purity percentage without an accompanying identity method is reporting how clean something is, not confirming that the something is retatrutide. Readers comparing documentation across listings generally treat an identity method as a baseline requirement, not an optional extra.

Purity Percentage and What It Represents

Purity on a COA is usually expressed as an HPLC area percentage: the proportion of the total detected signal attributable to the target peptide peak, with the remainder distributed across other peaks representing synthesis byproducts, truncated sequences, or residual solvents. A higher percentage means a smaller fraction of the sample is made up of these other components, not that the peptide is more potent per milligram in some separate sense.

This distinction matters when converting a purity figure into an estimate of actual peptide mass. A vial labeled with a nominal content of 10 mg, accompanied by a certificate of analysis reporting 98.6% purity, corresponds to roughly 9.86 mg of material attributable to the target peptide by that assay: 10 × 0.986 = 9.86. The remaining 0.14 mg, or 1.4% of the labeled mass, is not “impurity” in a uniform sense — it is whatever the chromatography run detected as separate from the main peak, which can include harmless synthesis residue as well as genuine byproducts. Recomputing the same figure a second way confirms it: 100% − 98.6% = 1.4%, and 1.4% of 10 mg is 0.14 mg, leaving 9.86 mg. A certificate that states purity but omits the method used to calculate it (area percentage versus a mass-based method, for instance) is giving a number without the context needed to compare it against a different lab’s figure.

Net Content and Fill Weight

Separate from purity, some certificates report net content or fill weight: a measured check on how much material is actually in the vial relative to the label claim. This figure exists because lyophilization and vial-filling introduce their own variance independent of chemical purity — a vial could contain chemically pure retatrutide while still being underfilled relative to its stated milligram amount, or overfilled. Not every COA includes this measurement, and its absence does not necessarily indicate a problem; it simply means the document is limited to identity and purity claims rather than a completeness check on fill volume.

A Field-by-Field Reference Table

The table below summarizes what each commonly listed COA field is intended to confirm and what a reader can reasonably check about it.

COA Field	What It Reports	What to Check
Identity (HPLC/MS)	Confirms the sample matches the reference structure	Method is named; result compared to a stated reference standard
Purity (%)	Proportion of signal attributable to the target peptide	Method disclosed (area%, mass-based); testing date present
Net content / fill weight	Measured mass in the vial versus the labeled amount	Whether this line exists at all — many COAs omit it
Appearance	Physical description, typically a white to off-white lyophilized solid	Matches other listing photos or descriptions
Endotoxin	Bacterial endotoxin level relevant to handling protocols	Units stated (commonly EU/mg or EU/mL) and method named
Lot or batch number	Ties the document to one specific production run	Matches the number printed on the vial or box label
Test date	When the analysis was performed	Reasonably close to the batch’s manufacture date

Lot Numbers and Traceability

Every field on a certificate of analysis is only meaningful if it is tied to the correct vial, which is what the lot or batch number is for. A COA with no lot number, or one where the printed lot number does not match the vial in hand, cannot be treated as documentation for that specific vial regardless of how thorough the testing described in it looks — it may be a real report for a different batch entirely, or a generic template. Cross-checking the lot number printed on the vial label against the number on the certificate is a basic first step before reading any of the numeric results.

Comparing Documentation Practices Across Sources

Because testing methods, purity calculation approaches, and field naming are not standardized across the industry, comparing a retatrutide certificate of analysis from one supplier against another requires looking at whether the same categories of information are present, not just whether the purity number is higher. Sourcing documentation that consistently discloses identity method, purity method, and lot traceability, such as the reference material published alongside retatrutide, gives a reader a fixed point of comparison when a different listing’s certificate is missing one of those fields.

Common Gaps Worth Noticing

A handful of patterns show up repeatedly in incomplete or low-effort certificates: a purity percentage with no stated method, an identity section that names a technique but not a reference standard, a lot number that does not appear anywhere on the physical vial, or a test date that is missing entirely. None of these gaps prove that a batch was mishandled, but each one narrows how much a reader can actually conclude from the document, since a COA is only as useful as the specificity of what it discloses.

Summary

Reading a retatrutide certificate of analysis comes down to checking a small, consistent set of fields — identity method, purity percentage and how it was calculated, net content where it’s reported, endotoxin data, and a lot number that matches the physical vial — rather than treating a single high purity figure as a complete picture. A document that names its methods and ties its results to a specific traceable batch gives a reader more to work with than one that reports a number alone, and comparing certificates field by field across listings is a more reliable approach than comparing purity percentages in isolation.